Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$4.84 - $6.91 $1,650 - $2,356
-341 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$5.11 - $7.64 $224 - $336
-44 Reduced 11.43%
341 $2,000
Q4 2020

Feb 10, 2021

SELL
$3.48 - $6.58 $104 - $197
-30 Reduced 7.23%
385 $2,000
Q1 2020

May 14, 2020

BUY
$2.3 - $5.5 $954 - $2,282
415 New
415 $1,000

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $47.1M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.